Swanhill Capital

1DOC3 is an e-health platform dedicated to connecting Spanish-speaking individuals with licensed doctors to address their health-related queries. By facilitating personalized interactions, users can receive expert answers to their health questions through various mediums, including web, mobile applications, SMS, and USSD, ensuring accessibility even in areas with limited internet connectivity. The platform not only empowers patients to resolve their health concerns but also enables doctors to enhance their online reputation, attract new patients, and contribute to a comprehensive database of health-related questions and answers in Spanish. This approach helps users maintain their well-being while supporting companies in promoting a healthier workforce.

Cohero Health, Inc. is a digital respiratory health company that focuses on developing solutions for the management of asthma and chronic obstructive pulmonary disease. The firm offers a connected health platform that includes the BreatheSmart app, which provides personalized reminders for medication adherence, tracks inhaler usage, measures lung function, and monitors symptoms and environmental conditions. Cohero Health also supplies mSpirometer lung function sensors and HeroTracker, a Bluetooth-enabled inhaler tracker for both control and rescue medications. Additionally, the company offers BreatheSmart Connect, a Software-as-a-Service solution that facilitates remote monitoring and communication between patients and healthcare providers. Founded in 2012 and headquartered in New York, Cohero Health operates as a subsidiary of AptarGroup, Inc.